Gevo Inc (NASDAQ:GEVO) was the target of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 319,600 shares, a decline of 9.7% from the May 30th total of 353,900 shares. Based on an average daily volume of 187,000 shares, the short-interest ratio is currently 1.7 days. Approximately 3.9% of the shares of the company are sold short.
In related news, insider Timothy J. Cesarek purchased 25,000 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was acquired at an average price of $1.91 per share, with a total value of $47,750.00. Following the completion of the acquisition, the insider now owns 30,000 shares of the company’s stock, valued at approximately $57,300. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.41% of the company’s stock.
A hedge fund recently bought a new stake in Gevo stock. Wedbush Securities Inc. acquired a new position in Gevo Inc (NASDAQ:GEVO) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 30,500 shares of the energy company’s stock, valued at approximately $67,000. Wedbush Securities Inc. owned 0.26% of Gevo as of its most recent SEC filing. Institutional investors and hedge funds own 8.55% of the company’s stock.
Shares of NASDAQ GEVO traded up $0.02 during mid-day trading on Friday, reaching $2.28. The company’s stock had a trading volume of 122,526 shares, compared to its average volume of 174,911. The company has a market cap of $27.10 million, a price-to-earnings ratio of -0.44 and a beta of 2.76. The firm’s fifty day simple moving average is $2.03. Gevo has a 52 week low of $1.79 and a 52 week high of $4.97.
Gevo (NASDAQ:GEVO) last released its quarterly earnings data on Wednesday, May 8th. The energy company reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.16). The business had revenue of $6.40 million during the quarter, compared to the consensus estimate of $5.57 million. Gevo had a negative return on equity of 27.80% and a negative net margin of 101.89%. As a group, research analysts anticipate that Gevo will post -1.47 EPS for the current fiscal year.
Several analysts have issued reports on the company. ValuEngine raised Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Monday, April 1st. HC Wainwright boosted their price target on Largo Resources from C$5.10 to C$5.20 in a report on Thursday, March 28th. Finally, Zacks Investment Research lowered EXACT Sciences from a “hold” rating to a “sell” rating in a report on Tuesday, July 2nd.
Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.
Featured Story: What is a Derivative?
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.